Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists
US7615550B2 · kind B2 · utility
16Cited by
6References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2003 |
| Grant date | Nov 10, 2009 |
| Priority date | — |
| Expiry date | Oct 27, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to novel piperazine and azepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurodegenerative disorders including Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.